IN2013CH02437A - - Google Patents

Download PDF

Info

Publication number
IN2013CH02437A
IN2013CH02437A IN2437CH2013A IN2013CH02437A IN 2013CH02437 A IN2013CH02437 A IN 2013CH02437A IN 2437CH2013 A IN2437CH2013 A IN 2437CH2013A IN 2013CH02437 A IN2013CH02437 A IN 2013CH02437A
Authority
IN
India
Prior art keywords
relates
present
solid formulation
imatinib
pharmaceutically acceptable
Prior art date
Application number
Inventor
Reddy Ramireddy Vijaybhaskar
Reddy Vatti Sumanth
Original Assignee
Vijaybhaskar Reddy Ramireddy Sumanth Reddy Vatti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vijaybhaskar Reddy Ramireddy Sumanth Reddy Vatti filed Critical Vijaybhaskar Reddy Ramireddy Sumanth Reddy Vatti
Priority to IN2437CH2013 priority Critical patent/IN2013CH02437A/en
Publication of IN2013CH02437A publication Critical patent/IN2013CH02437A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The technical field of the present invention relates to solid formulation of anticancer agent. More particularly, the present invention relates to solid formulation of Imatinib and its pharmaceutically acceptable salts.
IN2437CH2013 2013-06-04 2013-06-04 IN2013CH02437A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2437CH2013 IN2013CH02437A (en) 2013-06-04 2013-06-04

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2437CH2013 IN2013CH02437A (en) 2013-06-04 2013-06-04

Publications (1)

Publication Number Publication Date
IN2013CH02437A true IN2013CH02437A (en) 2015-10-09

Family

ID=54396641

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2437CH2013 IN2013CH02437A (en) 2013-06-04 2013-06-04

Country Status (1)

Country Link
IN (1) IN2013CH02437A (en)

Similar Documents

Publication Publication Date Title
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2021011906A (en) Delayed release compositions of linaclotide.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
PH12016500953A1 (en) Tricyclic compounds as anticancer agents
MX2015008627A (en) Boronic acid derivatives and therapeutic uses thereof.
MX2020005181A (en) Aminopyridine derivatives as tam family kinase inhibitors.
JOP20140114B1 (en) Heterocyclic compounds and their uses
MX2020001756A (en) Benzoquinolone inhibitors of vmat2.
UA115357C2 (en) Pyridin-4-yl derivatives
MX2015012416A (en) Heterocyclic compounds and their uses.
IN2013MU03641A (en)
IN2013MU03918A (en)
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX2015016603A (en) Corticosteroid compositions.
IN2013MU01111A (en)
GEP20217236B (en) Composition comprising pentose and polyphenolic compound
IN2014DN06617A (en)
MX367773B (en) Solid salt form of alpha-6-mpeg6-o-hydroxycodone as opioid agonists and uses thereof.
IN2013CH04314A (en)
WO2014122671A3 (en) Solid oral compositions of saxagliptin
IN2013CH02437A (en)
IN2014KN02584A (en)
IN2013MU02469A (en)
IN2013MU03801A (en)